Alligator Bioscience: Positive Topline Results
Research Note
2024-01-30
07:16
Redeye increases its base case after the positive topline results from OPTIMIZE-1, the phase II study of mitazalimab in pancreatic cancer.
RR
Richard Ramanius
Disclosures and disclaimers